Plain-English translation of NCT05564091 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether combining cataract surgery with a newer glaucoma procedure called ab-interno canaloplasty (using the iTrack Advance device) works better than cataract surgery alone for people who have both cataracts and mild to moderate glaucoma. The study will compare how well the combination approach lowers eye pressure compared to cataract surgery by itself. You'll be followed for 24 months to see which approach gives you better results.
Many people with glaucoma also develop cataracts, so doctors often perform both surgeries together. This trial exists to find out whether adding this newer glaucoma procedure during your cataract surgery gives you better control of eye pressure long-term, potentially reducing your need for glaucoma eye drops.
You likely qualify if…
You likely don't qualify if…
If you qualify and enroll, you'll be randomly assigned to either receive cataract surgery combined with the glaucoma procedure, or cataract surgery alone. You'll have surgery as the main intervention, followed by regular follow-up visits over 24 months to check your eye pressure, vision, and how well the procedure is working. These visits will include standard eye exams to monitor your glaucoma control.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
United States
Germany